News Focus
News Focus
Followers 7
Posts 776
Boards Moderated 0
Alias Born 12/05/2013

Re: TheHound post# 144860

Wednesday, 04/13/2016 9:08:08 AM

Wednesday, April 13, 2016 9:08:08 AM

Post# of 405214
http://finance.yahoo.com/news/cellceutix-receives-preliminary-approval-clinical-140000935.html

He has worked diligently with our CRO (for the planned Phase 3 ABSSSI study). They already have selected the first sites for the study that can start once we get the final protocol approval from the FDA. I wish him and his family well in his new endeavor," said Mr. Ehrlich
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y